The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Mutations of sodium channel alpha subunit type 1 (SCN1A) in intractable childhood epilepsies with frequent generalized tonic-clonic seizures
Abstract
A group of infant onset epilepsies manifest very frequent generalized tonic-clonic seizures (GTC) intractable to medical therapy, which may or may not be accompanied by minor seizures such as myoclonic seizures, absences and partial seizures. They include severe myoclonic epilepsy in infancy (SMEI) and intractable childhood epilepsy with GTC (ICEGTC). They are commonly associated with fever-sensitivity, family history of seizure disorders and developmental decline after seizure onset. Mutations of the neuronal voltage-gated sodium channel alpha subunit type 1 gene (SCN1A) were recently reported in SMEI patients. To clarify the genotypic differences in this group of epilepsies, we searched for SCN1A abnormalities in 25 patients with SMEI and 10 with ICEGTC, together with the family members of 15 patients. Frameshift mutations in SCN1A were observed in four patients, nonsense mutations in five patients, missense mutations in 21 patients, other mutations in two patients and no mutation in five patients. SMEI patients showed nonsense mutations, frameshifts, or missense mutations, while ICEGTC patients showed only missense mutations. Study of both parents of 11 patients revealed that the mutations in these patients were de novo. However, two mothers had the same missense mutations as their ICEGTC children, and they had generalized epilepsy with febrile seizures plus. Here we suggest that SMEI and ICEGTC represent a continuum with minor phenotypic and genotypic differences.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Genomic sequencing data indicate that a number of mutations in the Scn1a gene contribute to a spectrum of different epileptic disorders affecting children, including de novo (Claes et al., 2001; Fujiwara et al., 2003) as well as missense, frame-shift, and nonsense mutations (Fujiwara et al., 2003).”
From The Perineuronal ‘Safety’ Net? Perineuronal Net Abnormalities in Neurological Disorders (2018) · cites this paper as Fujiwara et al., 2003
Citations
Cites
De Novo Mutations in the Sodium-Channel Gene SCN1A Cause Severe Myoclonic Epilepsy of Infancy
Claes, L., Del-Favero, J., Ceulemans, B., Lagae, L., Van Broeckhoven, C., & De Jonghe, P. (2001) · The American Journal of Human Genetics · doi:10.1086/320609 · Cited by 1,292
Mutations of SCN1A, encoding a neuronal sodium channel, in two families with GEFS+2
Escayg, A., MacDonald, B. T., Meisler, M. H., Baulac, S., Huberfeld, G., An-Gourfinkel, I., Brice, A., LeGuern, E., Moulard, B., Chaigne, D., et al. (2000) · Nature Genetics · doi:10.1038/74159 · Cited by 996
(2005) · Cited by 944
Guerrini, R. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68182-8 · Cited by 848
Scheffer, I. E. (1997) · Brain · doi:10.1093/brain/120.3.479 · Cited by 758
Hughes, J. R. (1990) · Electroencephalography and Clinical Neurophysiology · doi:10.1016/0013-4694(90)90063-p · Cited by 503
Harkin, L. A., Bowser, D. N., Dibbens, L. M., Singh, R., Phillips, F., Wallace, R. H., Richards, M. C., Williams, D. A., Mulley, J. C., Berkovic, S. F., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/338710 · Cited by 441
Neuronal Sodium-Channel α1-Subunit Mutations in Generalized Epilepsy with Febrile Seizures Plus
Wallace, R. H., Scheffer, I. E., Barnett, S., Richards, M. C., Dibbens, L. M., Desai, R. R., Lerman‐Sagie, T., Lev, D., Mazarib, A., Brand, N. R., et al. (2001) · The American Journal of Human Genetics · doi:10.1086/319516 · Cited by 343
Escayg, A., Heils, A., MacDonald, B. T., Haug, K., Sander, T., & Meisler, M. H. (2001) · The American Journal of Human Genetics · doi:10.1086/319524 · Cited by 276
Frequent mutations of SCN1A in severe myoclonic epilepsy in infancy
Sugawara, T., Mazaki-Miyazaki, E., Fukushima, K., 下村, 次., Fujiwara, T., Hamano, S., Inoue, Y., & Yamakawa, K. (2002) · Neurology · doi:10.1212/wnl.58.7.1122 · Cited by 235
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–300 of 344
Genetics of idiopathic epilepsies
Nabbout, R., & Scheffer, I. E. (2013) · Handbook of clinical neurology · doi:10.1016/b978-0-444-52891-9.00059-2 · Cited by 17
Zamponi, N., Passamonti, C., Petrelli, C., Veggiotti, P., Baldassari, C., Verrotti, A., Capovilla, G., Viri, M., Coppola, G., & Vignoli, A. (2013) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2013.09.016 · Cited by 17
Effect of CYP2C19 polymorphisms on stiripentol administration in Japanese cases of Dravet syndrome
Kouga, T., Shimbo, H., Iai, M., Yamashita, S., Ishii, A., Ihara, Y., Hirose, S., Yamakawa, K., & Osaka, H. (2014) · Brain and Development · doi:10.1016/j.braindev.2014.04.003 · Cited by 17
Sugiura, Y., Ogiwara, I., Hoshi, A., Yamakawa, K., & Ugawa, Y. (2012) · Epilepsia · doi:10.1111/j.1528-1167.2012.03467.x · Cited by 16
“Rhodes et al. (2004) have reported that two mutations of the same residue cause GEFS+ (R1648H) and SMEI (R1648C), Figure 2.”
BackgroundInfluentialLipid Regulation of Sodium Channels
D’Avanzo, N. (2016) · Current topics in membranes · doi:10.1016/bs.ctm.2016.04.003 · Cited by 17
Kariuki, S. M., Abubakar, A. A., Stein, A. L., Marsh, K., & Newton, C. R. J. C. (2016) · Epilepsia Open · doi:10.1002/epi4.12035 · Cited by 16
Yao, C., Williams, A. J., Hartings, J. A., Lu, X., Tortella, F. C., & Dave, J. R. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.02.008 · Cited by 16
Condon, C., Parkerson, K. A., Dandurand, A., Fei, W., Howse, C., Mayhew, M., Whyman, S., Ventola, P. E., Meskis, M. A., Sullivan, J., et al. (2025) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2025.110381 · Cited by 15
Two Novel Mutations in SCN1A Gene in Iranian Patients with Epilepsy
Ebrahimi, A., Houshmand, M., Tonekaboni, S. H., Fallah, M., Zainali, S., & Moghaddasi, M. (2010) · Archives of Medical Research · doi:10.1016/j.arcmed.2010.04.007 · Cited by 15
Koch, N. A., Sonnenberg, L., Hedrich, U. B. S., Lauxmann, S., & Benda, J. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1194811 · Cited by 13
Ion Channels and Their Inhibitors
Gupta, S. P. (2011) · Springer eBooks · doi:10.1007/978-3-642-19922-6 · Cited by 16
SCN2A and Its Related Epileptic Phenotypes
Praticò, A. D., Giallongo, A., Arrabito, M., D'Amico, S., Gauci, M. C., Lombardo, G., Polizzi, A., Falsaperla, R., & Ruggieri, M. (2021) · Journal of Pediatric Neurology · doi:10.1055/s-0041-1727097 · Cited by 13
Shibata, A., Kasai, M., Terashima, H., Hoshino, A., Miyagawa, T., Kikuchi, K., Ishii, A., Matsumoto, H., Kubota, M., Hirose, S., et al. (2020) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2020.116808 · Cited by 13
Muthugovindan, D., & Hartman, A. L. (2010) · The Neurologist · doi:10.1097/nrl.0b013e3181d9d6b7 · Cited by 13
Genetics of idiopathic generalized epilepsy: An overview
Munshi, A., Prasad, D. K. V., & Satyanarayana, U. (2013) · Neurology India · doi:10.4103/0028-3886.125240 · Cited by 13
Chen, Z., Chen, S., Chen, L., Zhou, J., Dai, Q., Yang, L.-B., Li, X., & Zhou, L. (2009) · Brain Research · doi:10.1016/j.brainres.2009.03.012 · Cited by 13
“…with febrile seizures plus syndrome, severe myoclonic epilepsy of infancy, intractable childhood epilepsy with generalized tonic–clonic seizures and infantile spasms (Claes et al., 2001; Escayg et al., 2000; Fujiwara et al., 2003; Nabbout et al., 2003; Rhodes et al., 2005; Wallace et al., 2003).”
Age-related epileptic encephalopathies
Guerrini, R., & Pellock, J. M. (2012) · Handbook of clinical neurology · doi:10.1016/b978-0-444-52898-8.00011-2 · Cited by 13
Benign Familial Neonatal Convulsions: Novel Mutation in a Newborn
Lee, I., Chen, J., Chen, Y.-J., Yu, J., & Su, P. (2009) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2008.12.004 · Cited by 13
“Examples include generalized epilepsy with febrile seizure-plus and severe myoclonus epilepsy [6,10].”
BackgroundMolecular basis of severe myoclonic epilepsy in infancy
Yamakawa, K. (2009) · Brain and Development · doi:10.1016/j.braindev.2008.11.015 · Cited by 13
Identification of five novel SCN1A variants
Zeng, B., Zhang, H., Lu, Q., Fu, Q., Yang, Y. X., Wan, L., Ma, P., Feng, C., Qin, J., Luo, L., et al. (2023) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2023.1272748 · Cited by 12
Leber’s Hereditary Optic Neuropathy Mutations Associated With Infantile-Onset Myoclonic Epilepsy
Frye, R. E. (2011) · Journal of Child Neurology · doi:10.1177/0883073810391531 · Cited by 12
“Dravet’s severe myoclonic epilepsy in infancy is particularly interesting as it is associated with refractory epilepsy with a predominance of myoclonus seizures, a deterioration in neurological function and cognitive development with the onset of seizures, fever-precipitated seizures, a characteristic age of onset, an…”
BackgroundAntiepileptic drugs for the treatment of severe myoclonic epilepsy in infancy
Brigo, F., Storti, M., & Felice, A. D. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010483 · Cited by 12
Nicita, F., Spalice, A., Papetti, L., Ursitti, F., Parisi, P., Gennaro, E., Zara, F., & Iannetti, P. (2010) · Journal of Child Neurology · doi:10.1177/0883073810365737 · Cited by 11
“These SMEI variants have been renamed as borderline severe myoclonic epilepsy of infancy (SMEB) and intractable childhood epilepsy with generalized tonic-clonic seizures (ICE-GTC).(7,8) It is well-known that GEFSþ, SMEI, SMEB, and ICE-GTC could share some clinical features (recurrent and prolonged febrile seizures) an…”
BackgroundDe novo SCN1A, SCN8A, and CLCN2 mutations in childhood absence epilepsy
Xie, H., Su, W., Pei, J., Zhang, Y., Gao, K., Li, J., Ma, X., Zhang, Y., Wu, X., & Jiang, Y. (2019) · Epilepsy Research · doi:10.1016/j.eplepsyres.2019.04.005 · Cited by 11
Clinical and Functional Features of Epilepsy-Associated In-Frame Deletion Variants in SCN1A
Wang, J., Tang, B., Sheng, W.-X., Hua, L.-D., Zeng, Y., Fan, C.-X., Deng, W., Gao, M., Zhu, W., He, N., et al. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.828846 · Cited by 11
Antiepileptic drugs for the treatment of infants with severe myoclonic epilepsy
Brigo, F., Igwe, S. C., & Bragazzi, N. L. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010483.pub4 · Cited by 10
Primary Generalized Epilepsy during Infancy and Early Childhood
Shahar, E. M., Barak, S., Andraus, J., & Kramer, U. (2004) · Journal of Child Neurology · doi:10.1177/088307380401900302.170 · Cited by 11
Epileptic encephalopathies in infancy and early childhood
Panayiotopoulos, C. P. (2010) · Springer eBooks · doi:10.1007/978-1-84628-644-5_10 · Cited by 11
Voltage-gated sodium channels (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database
Catterall, W. A., Goldin, A. L., & Waxman, S. G. (2019) · IUPHAR/BPS Guide to Pharmacology CITE · doi:10.2218/gtopdb/f82/2019.4 · Cited by 10
Double somatic mosaicism in a child with Dravet syndrome
Muir, A. M., King, C., Schneider, A., Buttar, A. S., Scheffer, I. E., Sadleir, L. G., & Mefford, H. C. (2019) · Neurology Genetics · doi:10.1212/nxg.0000000000000333 · Cited by 10
Magalhães, P. H. M., de Moraes, H. T., Athié, M. C. P., Secolin, R., & Lopes‐Cendes, Í. (2019) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2019.07.029 · Cited by 10
Involvement of Scn1b and Kcna1 ion channels in audiogenic seizures and PTZ-induced epilepsy
Li, X., Kuang, H., Jiang, N., & Hu, Y. (2005) · Epilepsy Research · doi:10.1016/j.eplepsyres.2005.08.002 · Cited by 9
Mazzuca, M., Lesage, F., & Lazdunski, M. (2006) · Epileptic Disorders · doi:10.1684/j.1950-6945.2006.tb00194.x · Cited by 9
“The phenotypic spectrum of SCN1A mutations was extended to other severe infantile epilepsies (Fujiwara et al., 2003).”
BackgroundSudden Unexpected Death in Epilepsy: Central Respiratory Chemoreception
Dereli, A. S., Apaire, A., & Tahry, R. E. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26041598 · Cited by 8
Peripheral temperature dysregulation associated with functionally altered NaV1.8 channels
Loose, S., Lischka, A., Kuehs, S., Nau, C., Heinemann, S. H., Kurth, I., & Leipold, E. (2023) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-023-02856-2 · Cited by 8
“1 associated with epilepsy disorders [16, 21, 22, 46], NaV1.”
NovelSCN1Amutations in Indonesian patients with severe myoclonic epilepsy in infancy
Herini, E. S., Gunadi, G., van Kempen, M. J. A., Yusoff, S., Sutaryo, S., Sunartini, Patria, S. Y., Matsuo, M., Lindhout, D., & Nishio, H. (2009) · Pediatrics International · doi:10.1111/j.1442-200x.2009.02916.x · Cited by 8
An electroclinical study of absence seizures in Dravet syndrome
Tsuda, Y., Oguni, H., Sakauchi, M., & Ōsawa, M. (2012) · Epilepsy Research · doi:10.1016/j.eplepsyres.2012.07.010 · Cited by 8
“, proband with DS core phenotype, sibling with DS orderline phenotype, or parent with FS or even no sympoms (Fujiwara et al., 2003; Guerrini et al., 2010; Kimura t al., 2005; Morimoto et al., 2006; Nabbout et al., 2003; uls et al., 2010).”
BackgroundDevelopment of individualized medicine for epilepsy based on genetic information
Kaneko, S., Yoshida, S., Kanai, K., Yasui‐Furukori, N., & Iwasa, H. (2008) · Expert Review of Clinical Pharmacology · doi:10.1586/17512433.1.5.661 · Cited by 8
Parisi, P., Verrotti, A., Paolino, M. C., Castaldo, R., Ianniello, F., Ferretti, A., Chiarelli, F., & Villa, M. P. (2011) · The Italian Journal of Pediatrics/Italian journal of pediatrics · doi:10.1186/1824-7288-37-58 · Cited by 8
“Japanese authors described patients with uncomplete SMEI phenotype, and have named these variants as borderline severe myoclonic epilepsy of infancy (SMEB) and intractable childhood epilepsy with generalized tonicclonic seizures (ICE-GTC) [45,46].”
BackgroundZhou, C., Satpute, V., Yip, K. L., Anderson, L. L., Hawkins, N. A., Kearney, J. A., & Arnold, J. C. (2024) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2024.106836 · Cited by 6
Sodium Channelopathies in Human and Animal Models of Epilepsy and Neurodevelopmental Disorders
Yamakawa, K., Meisler, M. H., & Isom, L. L. (2024) · Oxford University Press eBooks · doi:10.1093/med/9780197549469.003.0044 · Cited by 8
Jones, L., Peters, C. H., Rosch, R. E., Owers, M., Hughes, E., Pal, D. K., & Ruben, P. C. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.788192 · Cited by 8
“Drug resistance is not uncommon in epilepsy associated with SCN1A variants, and has also been reported in many of the mixed-function variants discussed above (Claes et al., 2003; Fujiwara et al., 2003; Rhodes et al., 2004; Sadleir et al., 2017).”
BackgroundNaseer, M. I., Abdulkareem, A. A., Rasool, M., Algahtani, H. A., Muthaffar, O. Y., & Pushparaj, P. N. (2022) · Frontiers in Pediatrics · doi:10.3389/fped.2022.919996 · Cited by 7
“Moreover, ICE-GTC and GEFS+ in the form of missense type were first described by (1, 6).”
BackgroundMolecular biology of channelopathies: impact on diagnosis and treatment
AVANZINI, G., Franceschetti, S., Avoni, P., & Liguori, R. (2004) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.4.3.519 · Cited by 7
Zhou, X., Xu, H., Cai, X., Tang, B., Liu, X., Shi, Y., Zheng, J., Liao, W., & Yu, L. (2021) · Epilepsy Research · doi:10.1016/j.eplepsyres.2021.106711 · Cited by 6
Sodium Channel Gene Mutations in Children with GEFS+ and Dravet Syndrome: A Cross Sectional Study.
Tonekaboni, S. H., Ebrahimi, A., Bali, M. B., Houshmand, M., Moghaddasi, M., Taghdiri, M. M., & Nasehi, M. (2013) · Iranian journal of child neurology. · doi:10.22037/ijcn.v7i2.4074 · Cited by 6
Dravet syndrome: a new causative SCN 1A mutation?
Poryo, M., Clasen, O., Oehl‐Jaschkowitz, B., Christmann, A., Gortner, L., & Meyer, S. (2017) · Clinical Case Reports · doi:10.1002/ccr3.787 · Cited by 6
Genetic screening of Scandinavian families with febrile seizures and epilepsy or GEFS+
Selmer, K. K., EGELAND, T., Solaas, M. H., Nakken, K. O., Kjeldsen, M. J., Friis, M. L., Brandal, K., Corey, L. A., & Undlien, D. E. (2007) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2007.00941.x · Cited by 6
Are the epilepsies disorders of ion channels?
Celesia, G. G. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13028-0 · Cited by 6
Sheth, H. J., Pancholi, D., Bhavsar, R., Mannan, A. U., Ganapathy, A., Chaudhari, M., Shah, S. V., Solanki, D., Sheth, F. J., & Sheth, J. J. (2021) · Neurology India · doi:10.4103/0028-3886.333475 · Cited by 6
Sadiq, M. (2020) · Cited by 5
Role of SCN1A and SCN2A Gene Polymorphisms in Epilepsy Syndromes-A Study from India
Bhat, M. A., Guru, S. A., Mir, R., Waza, A. A., Zuberi, M., Sumi, M. P., Bodeliwala, S., Samadhiya, A., Puri, V., & Saxena, A. (2018) · Journal of Neurology and Neuroscience · doi:10.21767/2171-6625.1000238 · Cited by 5
“Defects in SCN1A gene might lead to myoclonic epilepsy in infancy (SMEI), generalized epilepsy with febrile seizures (GEFS) plus type 2, and intractable childhood epilepsy with generalized tonic-clonic seizures [34,35].”
BackgroundGitto, R., Luca, L. D., & Sarro, G. D. (2010) · Burger's Medicinal Chemistry and Drug Discovery · doi:10.1002/0471266949.bmc099.pub2 · Cited by 5
Diagnóstico temprano del síndrome de Dravet: aportaciones de la clínica y la biología molecular
Sánchez-Carpintero, R. (2011) · Revista de Neurología · doi:10.33588/rn.5211.2010771 · Cited by 4
Gowda, V. K., Battina, M., Vegda, H., Srinivasan, V. M., Chikara, S. K., Mishra, A., Shivappa, S. K., & Benakappa, N. (2021) · Journal of Pediatric Genetics · doi:10.1055/s-0041-1731020 · Cited by 4
Molecular Genetics of Dravet Syndrome
Weckhuysen, S., Suls, A., & Jonghe, P. D. (2012) · Wiley eBooks · doi:10.1002/9780470015902.a0023846 · Cited by 4
Advances in Design and Development of Sodium Channel Blockers
Zuliani, V., Amori, L., & Rivara, M. (2011) · Springer eBooks · doi:10.1007/978-3-642-19922-6_4 · Cited by 3
The Economic Impact of Medication-Resistant Epilepsy
Begley, C. E., & Jeong, S. (2020) · Cambridge University Press eBooks · doi:10.1017/9781316492376.004 · Cited by 3
Mahdieh, N., Mikaeeli, S., Badv, R. S., Shirazi, A. G., Maleki, M., & Rabbani, B. (2018) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2018.01.030 · Cited by 3
Identification of novel epilepsy genetics and development of advanced diagnostic approaches
Veerabathiran, R., & Iyshwarya, B. K. (2025) · Brain Disorders · doi:10.1016/j.dscb.2025.100202 · Cited by 2
Characteristic spatial and frequency distribution of mutations in SCN1A
Zhang, M., Guo, J., Li, B., Liu, K., Zhao, J., Zhang, J., Lin, X., Tang, B., Wang, J., Liao, W., et al. (2024) · Acta Epileptologica · doi:10.1186/s42494-024-00178-z · Cited by 2
“2b), owing to a hypermutable CpG dinucleotide that was reported 29 times (c.602 + 1G > A) [15–17].”
BackgroundRakib, A. I., Chowdhury, R., Bhuia, M. S., Hasan, M. S. A., Hasan, R., Ansari, S. A., Ansari, I. A., Ahmed, S., de Vasconcelos, J. E. L., Coutinho, H. D. M., et al. (2025) · South African Journal of Botany · doi:10.1016/j.sajb.2025.04.034 · Cited by 2
Medication-Resistant Epilepsy in Adults
Holtkamp, M., & Benninger, F. (2020) · Cambridge University Press eBooks · doi:10.1017/9781316492376.014 · Cited by 2
Shorvon, S. D., Andermann, F., & Guerrini, R. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9780511921001.007 · Cited by 2
¿Crisis febriles complejas o síndrome de Dravet?: Descripción de 3 casos clínicos
Hernández, M., Latorre, T. M., Herrera, M. P., & Troncoso, M. (2014) · Revista chilena de pediatría · doi:10.4067/s0370-41062014000500010 · Cited by 2
Crisis con fiebre en el primer año de vida: ¿epilepsia del espectro Dravet?
Sánchez-Carpintero, R., Núñez, M. T., Aznárez, N., & García, J. N. (2011) · Anales de Pediatría · doi:10.1016/j.anpedi.2011.10.001 · Cited by 2
“10 6 m 4 m 6 m 4 m Donorsplice 4 m 4a 12 4 m (6) 4 m (7) 3 a 2006”
InfluentialSugawara, T., Yoshida, S., Onodera, N., Wada, K., Hirose, S., & Kaneko, S. (2013) · Journal of Epileptology · doi:10.1515/joepi-2015-0001 · Cited by 2
Khamdiyeva, O., Tileules, Z., Baratzhanova, G., Perfilyeva, A. V., & Djansugurova, L. (2021) · Egyptian Journal of Medical Human Genetics · doi:10.1186/s43042-020-00123-y · Cited by 2
SCN1A and Its Related Epileptic Phenotypes
Sullo, F., Pasquetti, E., Patanè, F., Bianco, M. L., Marino, S. D., Polizzi, A., Falsaperla, R., Ruggieri, M., Zanghì, A., & Praticò, A. D. (2021) · Journal of Pediatric Neurology · doi:10.1055/s-0041-1727260 · Cited by 2
Teralı, K., Türkyılmaz, A., Sağer, S. G., & Çebi, A. H. (2023) · Clinical and Translational Science · doi:10.1111/cts.13679 · Cited by 2
Dam, V. V., & Korff, C. M. (2013) · Schweizer Archiv für Neurologie und Psychiatrie · doi:10.4414/sanp.2013.00174 · Cited by 2
Pharmacotherapy for Medication-Resistant Epilepsy
Powell, G. A., & Marson, A. G. (2020) · Cambridge University Press eBooks · doi:10.1017/9781316492376.016 · Cited by 2
Voltage-gated sodium channels (NaV) in GtoPdb v.2021.3
Catterall, W. A., Goldin, A. L., & Waxman, S. G. (2021) · IUPHAR/BPS Guide to Pharmacology CITE · doi:10.2218/gtopdb/f82/2021.3 · Cited by 2
The Physical Mechanism in Epilepsy - Understanding the Transition to SeizurePreprint
Aur, D. (2010) · Nature Precedings · doi:10.1038/npre.2010.5398.1 · Cited by 3
“…(Chu et al., 2010) decreased inhibitory neurotransmission (Turnbull et al., 2005), alteration in voltage-gated ion channels (Claes et al., 2001; Fujiwara et al., 2003; Wallace et al., 1998; Escayg and Goldin, 2010) complex changes in the neurochemistry of glutamate metabolism (e.g.…”
BackgroundEpilepsia mioclónica grave de la infancia (síndrome de Dravet). Aspectos genéticos
Herranz, J. L. (2003) · Revista de Neurología · doi:10.33588/rn.3701.2003227 · Cited by 2
Catterall, W. A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802002-9.00004-2 · Cited by 1
Psychiatric Comorbidities in Medication-Resistant Epilepsy
Kanner, A. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781316492376.023 · Cited by 1
Medication-Resistant Epilepsy Syndromes in Children
Pestana‐Knight, E., & Wyllie, E. (2020) · Cambridge University Press eBooks · doi:10.1017/9781316492376.013 · Cited by 1
Mazzuca, M., Lesage, F., & Lazdunski, M. (2004) · Epileptic Disorders · doi:10.1684/j.1950-6945.2004.tb00082.x · Cited by 1
“Dans les familles de patients présentant à la fois des EGCF+ et des EMSN, il semblerait, une fois encore, que d’autres facteurs environnementaux ou génétiques déterminent la gravité du phénotype [132, 133].”
BackgroundCentral nervous system/neuromuscular channelopathies
Zuberi, S. M. (2003) · European Journal of Paediatric Neurology · doi:10.1016/s1090-3798(03)00053-9 · Cited by 1
Ictal Vomiting as an Initial Symptom of Severe Myoclonic Epilepsy in Infancy: A Case Report
Hino‐Fukuyo, N., Haginoya, K., Togashi, N., Uematsu, M., Kitamura, T., Kakisaka, Y., Ishitobi, M., Wakusawa, K., Iinuma, K., Oguni, H., et al. (2009) · Journal of Child Neurology · doi:10.1177/0883073808327839 · Cited by 1
Dravet syndrome: A case report with a new missense substitution as 1274 Tyr > Asp
Moghaddasi, M., Mamarabadi, M., Ebrahimi, A., Tonekaboni, S. H., Zainali, S., & Houshmand, M. (2015) · Journal of Pediatric Neurology · doi:10.3233/jpn-2010-0452 · Cited by 1
Expanding spectrum of SCN1A-related phenotype with novel mutations
Kurul, S. H., Gürsoy, S., Ayanoğlu, M., Yiş, U., & Erçal, D. (2017) · The Turkish Journal of Pediatrics · doi:10.24953/turkjped.2017.05.010 · Cited by 1
Genetics in the identification of molecular pathogenic mechanisms of familial migrane.
Castro, M. J. M. E. (2011) · Cited by 1
Social Consequences of Medication-Resistant Epilepsy
Crepeau, A. Z., & Sirven, J. I. (2020) · Cambridge University Press eBooks · doi:10.1017/9781316492376.005 · Cited by 1
(2020) · Cambridge University Press eBooks · doi:10.1017/9781316492376 · Cited by 1
Voltage-gated sodium channels (NaV) in GtoPdb v.2023.1
Catterall, W. A., Goldin, A. L., & Waxman, S. G. (2023) · IUPHAR/BPS Guide to Pharmacology CITE · doi:10.2218/gtopdb/f82/2023.1 · Cited by 1
Jiménez-Arredondo, R. E., Brambila‐Tapia, A. J. L., Mercado-Silva, F. M., Magaña‐Torres, M. T., & Figuera, L. E. (2017) · Genetics and Molecular Research · doi:10.4238/gmr16029405 · Cited by 1
Jukkarwala, A., Menon, R. N., Sunesh, E. R., & Radhakrishnan, A. (2020) · Clinical EEG and Neuroscience · doi:10.1177/1550059420953735 · Cited by 1
Photosensitivity in Dravet Syndrome
Ceulemans, B., Schoonjans, A., & de Vel, A. V. (2020) · Springer eBooks · doi:10.1007/978-3-319-05080-5_23 · Cited by 1
Genetic studies of the common epilepsies: genome-wide association studies in the partial epilepsies
Catarino, C. B. (2014) · UCL Discovery (University College London) · Cited by 1
Genetic Counselling in Epilepsy
Zara, F. (2009) · Wiley eBooks · doi:10.1002/9781444316667.ch27 · Cited by 1
Vezzani, A. (2008) · Epilepsia · doi:10.1111/j.1528-1167.2007.01439_1.x · Cited by 1
The Natural History of Epilepsy
Lee, B., & Kim, S. (2020) · Cambridge University Press eBooks · doi:10.1017/9781316492376.001 · Cited by 1
Koch, N. A., Sonnenberg, L., Hedrich, U. B. S., Lauxmann, S., & Benda, J. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.01.16.524256 · Cited by 1
Desarrollo cognitivo en el síndrome de Dravet como modelo de encefalopatía epiléptica
Sánchez-Carpintero, R. (2013) · Revista de Neurología · doi:10.33588/rn.56s01.2012663
Spampanato, J. G., & Goldin, A. L. (2008) · Elsevier eBooks · doi:10.1016/b978-012373649-9.50013-2
“…epilepsy with generalized tonic-clonic seizures (ICEGTC) and severe myoclonic epilepsy of infancy (SMEI), a more severe form of GEFS (Claes et al. 2001, 2003; Fujiwara et al. 2003; Gennaro et al. 2003; Scheffer et al. 2001; Sugawara et al. 2002; Veggiotti et al. 2001; Wallace et al. 2003).”
BackgroundGenetic analysis of human absence epilepsy
Robinson, R. A. (2010) · UCL Discovery (University College London)
The clinical and genetic epidemiology of pediatric idiopathic epilepsy in Newfoundland and Labrador
Mahoney, K. (2014) · Memorial University Research Repository (Memorial University)
Epilepsy, Biomarkers, and Genes
Andrade, D. M. (2009) · Springer eBooks · doi:10.1007/978-90-481-2298-1_7
Metadata
- Authors
- Fujiwara, T.
- Affiliations
- National Epilepsy Center (JP)
- Corresponding author
- Fujiwara, T.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-03-01
- Volume
- 126
- Issue
- 3
- Pages
- 531-546
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2161749769
- Cited by
- 345
- References
- 32
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 5 · 2023: 8 · 2022: 7 · 2021: 13 · 2020: 36 · 2019: 6 · 2018: 5 · 2017: 10 · 2016: 11 · 2015: 14 · 2014: 19 · 2013: 19 · 2012: 12
- FWCI
- 13.67
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Brain (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmacological Effects and Toxicity Studies
- Keywords
- SCN1A, Dravet syndrome, generalized tonic-clonic seizures, missense mutations, frameshift mutation, nonsense mutation, de novo mutations, generalized epilepsy with febrile seizures plus, genotype-phenotype correlation, infantile epilepsy
- MeSH terms
- Adolescent, Adult, Body Temperature, Child, Child, Preschool, Seizures, Febrile, DNA Mutational Analysis, Epilepsy, Tonic-Clonic, Epilepsies, Myoclonic, Female, Heterozygote, Humans, Male, Nerve Tissue Proteins, Sodium Channels, Frameshift Mutation, Mutation, Missense, NAV1.1 Voltage-Gated Sodium Channel
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review